Loren Data Corp.

'

 
 

COMMERCE BUSINESS DAILY ISSUE OF FEBRUARY 20,1997 PSA#1786

National Cancer Institute, Research Contracts Branch, PCCS, Executive Plaza South, Room 635, Bethesda, Md 20892

A -- RESEARCH AND DEVELOPMENT -- PHASE 2 CLINICAL TRIAL OF CHEMOPREVENTIVE AGENTS -- A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF A NONSTERIODAL ANTI-INFLAMMATORY AGENT TO-BE-NAMED AND DFMO COMBINATION AGAINST VARIOUS ENDPOINTS OF COLORECTAL PATHOBIOLOGY IN A COHORT OF IN POC Theresa H. Shroff CNT N01-CN-75019 AMT $2,760,852 DTD 021597 TO University of California at Irvine, 115 Administrative Boulevard, Irvine, California 92717 E-MAIL: Theresa H. Shroff, shrofft@rec.nci.nih.gov. (0049)

Loren Data Corp. http://www.ld.com (SYN# 0359 19970220\A-0003.AWD)


A - Research and Development Index Page